Program Overview (5 mins)
Updating My Practice Following Fall Conferences 2019 (25 mins)
- Summary of the most important studies
- Key practice recommendations for the clinic
Question and Answer Session (15 mins)
Date / Time
Joseph J. Eron, MD
Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina
Princy N. Kumar, MD
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Chloe Orkin, MBChB, FRCP, MD
Professor of HIV
Queen Mary, University of London
Lead for HIV Research
Barts Health NHS Trust
The Royal London Hospital
London, United Kingdom
You are invited to attend a CME/CE-certified Webinar highlighting key take-home messages from the 2019 Fall Conferences.
The goal of this activity is to improve learners’ competence in translating the most clinically significant data from 3 important scientific meetings into practical management strategies for persons at risk of or infected with HIV infection.
This program is intended for physicians, pharmacists, and other healthcare providers who care for patients with HIV.
- Apply data from studies of ARV agents used to prevent HIV infection
- Devise management strategies based on the results of recent clinical studies of established ARV agents in HIV-infected patients
- Appropriately counsel patients regarding the anticipated clinical role of new and investigational ART regimens
USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Continuing Medical Education
USF Health designates this live activity for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
USF Health is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based program has been approved for 0.75 contact hour (0.075 CEU). Universal program number is as follows: (0230-9999-19-019-L01-P).
It is the responsibility of the pharmacy participant to ensure the provider has the learner’s birthday and e-Profile ID (ePID)/NABP number; it is the responsibility of the provider to submit to CPE Monitor participant information within 60 days of the activity for all participants who have attended, attested to their participation, and provided their ePID/NABP number and birthdate.
ACPE indicates it is the responsibility of the pharmacy professional to confirm the status of their NABP contact hours before 60 days past the activity. If there are any discrepancies, contact the provider immediately. You may contact USF Health through firstname.lastname@example.org.
Disclosure of Conflicts of Interest
USF Health adheres to ACCME, ANCC, and ACPE Standards regarding commercial support of continuing medical education. It is the policy of USF Health that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation.
The information provided at this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
If you have any questions relating to the continuing education accreditation of this activity, please contact USF Health at 813-224-7860 or email@example.com.